维普期刊资源整合服务平台（V6.5）

142篇 您的检索式：作者名="ALESSI MC"

选中清除导出查看参考文献查看引证文献引用追踪共8页首页上一页第1页下一页末页 /8 跳转

	题名	作者	年代	出处	被引量
1	Endothelial Cell markers and the risk of coronary heart disease:the prospective Epidemiological study of myocardial infarction(PRIME)study显示文摘	SIMON C ALESSI MC	2004	Circulation2004，109，：	1
2	PAI-1 produced ex vivo by human adipose tissue is relevant to PAI-1 blood level显示文摘	Morange PE Alessi MC Verdier M	1999	Arterioscler Thromb Vasc Biol1999，19，5：	1
3	Plasma TAFI antigen variations in healthy subjects显示文摘	Chetaille P Alessi MC Kouassi D	2000	Thromb Haemost2000，83，6：	1
4	Absence of PCR- detectable human papilloma virus in erythroplasia of Queyrat using a comparative control group 显示文摘	Nasca MR Potenza MC Alessi L	2010	Sex Transm Infect2010，86，3：	1
5	Plasminogen activator inhibitor-1 and atherosclerosis显示文摘	Juhan-Vague I Alessi MC	1993	Thromb Haemost1993，70，：	1
6	Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation 显示文摘	ALESSI MC BASDTELICA D MAVRI A	2003	Arterioscler Thromb Vasc Biol2003，23，7：	1
7	Endothelial cell markers and the risk of coronary heart disease:the Prospective Epidemiological Study of Myocardial Infarction(PRIME)study显示文摘	Simon C Alessi MC	2004	Circulation2004，109，11：	1
8	Endothelial cell markersand the risk of coronary heart disease:the Prospective Epidemio-logical Study of Myocardial Infarction(PRIME)study显示文摘	Morange PE Simon C Alessi MC	2004	Circu-lation2004，109，：	1
9	Clearance of tissueplasminogen activator ( t - pa) and t - PA/Plasminogen activatorinhib itortypel( PAI - 1 )tPA/PAI - 1 complex;relationship to elevated t - PA antigen in patients with high PAI- lactivityevels 显示文摘	Chandler WL Alessi MC Ailland MF	1997	Circulation1997，96，：	1
10	Metabolic endotoxemia initiates obesity and insulin resistance 显示文摘	Cani PD Amar J Iglesias MA Poggi M Knauf C Bastelica D Neyrinck AM Fava F Tuohy KM Chabo C Waget A Delm6e E Cousin B Sulpice T Chamontin B Ferrieres J Tanti JF Gibson OR Casteilla L Delzenne NM Alessi MC Burcelin R	2007	Diabetes2007，56，7：	1
11	Plasminogen activator inhibitor inflammation obesity,insulin resistance and vascular risk显示文摘	Juhan V Alessi MC Mavri A	2003	J Thromb Haemost2003，1，7：	1
12	Plasminogen activator in hibitor1 inflammation obesity insulin resistance and vascular risk显示文摘	Juhan VI Alessi MC Mavri A	2003	JThrombHaemost2003，1，7：	1
13	Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity显示文摘	Juhan-Vague I Alessi MC Morange PE	2000	Ann Med2000，32，1：	1
14	Metabolic deteminants are much more important than genetic polymorphisms in determining the PAI-1 activity and antigen plasma concentrations:a family study with part of the Stanislas Cohort显示文摘	Tregouet DA Alessi MC	1998	Arterioscler Thromb Vasc Biol1998，18，184：	1
15	Endothelial cell markers and the risk of coronary heart disease:the Prospective Epidemiological Study of Myocardial Infarction(PRIME)Study显示文摘	Morange PE Simon C Alessi MC	2004	Circulation2004，109，11：	1
16	Fibrinolgtil and in flammatorg processes in pleural effusions显示文摘	Philip JF Alessi MC Philip JC	1995	Eur Respir J1995，8，：	1
17	Contribution of PAI-1 in cardiovasculaRpathology显示文摘	Juhan-Vague I	2004	Arch Mal CoeuRVaiss2004，97，6：	1
18	Hypofibrinolysis and increaeed PAI-1 are linked to atherothronbosis via insulin resistance and obesity显示文摘	Juhan-Vague I Alessi MC Morange PE	2002	Ann Med2002，32，1：	1
19	Prognostic value ofplasma tissue factor and tissue factor pathway inhibitor forcardiovascular death in patients with coronary artery disease: theAtheroGene study显示文摘	Morange PE Blankenberg S Alessi MC	2007	J Thromb Haemost2007，5，3：	1
20	Plasma TAFI antigen variations in healthy subjects显示文摘	ALESSI MC KOUASSI D	2000	J Thromb Haemost2000，83，：	1

返回顶部每页显示：

共8页首页上一页第1页下一页末页 /8 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示